Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): A 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
Other Ingredients: Purified water, citric acid, vegetable glycerin, natural flavor, sucralose
It promotes lipolysis (fat breakdown), preserves lean muscle mass, improves sleep quality, enhances skin elasticity, and supports bone density
Early research explores adding muscle-preserving compounds to prevent the lean mass loss that accompanies rapid weight reduction
The Phase 2 data proved that starting higher doubles GI side effects with no benefit to long-term outcomes
US$ 29.92
US$ 20.88
US$ 28.56
